Asia · Financial press · The Economic Times
Cipla’s US recovery, biosimilar pipeline key to future growth prospects
Cipla's September-quarter earnings suffered due to a high base in its US business. The company reported sequential growth driven by its strong India business and branded…
Read the full article on The Economic Times Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (economictimes.indiatimes.com)


